I think they probably have and would expect the Faro's to make certain the CDC also knows of the technology and its significant advantages. If the CDC and WHO follow the science with the published Faro analysis and research findings that show the N-Assay to be head and shoulders above alternative technologies then what should occur is that it has to be adopted. For that matter, I just read of the loss of Medicare reimbursement revenues in the millions of dollars annually to several Florida hospitals due to infections they didn't detect prior to releasing patients. This is occurring all over the US and since the law is only now starting to "bite" I have to assume the Faro's and the NanoLogix CEO is on top of this as an incredible element of sales and marketing as the product capability is being "ramped up" as the Company CEO described recently. That's why I am just sitting and waiting with great expectations. The Faro's research shows the N-Assay way ahead of alternative detection/diagnostic technology so "Yay NanoLogix and thank you Faros".